SHAHAD JONNA: Open Payments
NPI 1962974253 · WEST BLOOMFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,625 in 104 payments from 14 companies in 2025. Trend: 2023 $1,108 · 2024 $1,961 · 2025 $2,625
Food & beverage: $2,625
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $759 |
| ABBVIE INC. | 20 | $414 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $265 |
| Tris Pharma Inc | 5 | $185 |
| Axsome Therapeutics, Inc. | 6 | $174 |
| Lundbeck LLC | 7 | $170 |
| Otsuka America Pharmaceutical, Inc. | 8 | $159 |
| Alkermes, Inc. | 12 | $158 |
| Neurocrine BioSciences, Inc. | 6 | $147 |
| PFIZER INC. | 1 | $113 |
Products named: HETLIOZ, FANAPT, CAPLYTA, VRAYLAR, REXULTI, Dyanavel XR, Auvelity, QULIPTA.
Industry payments across MI — which companies pay providers there.
